Bristol-Myers Squibb shares rose in premarket trade on Friday after the Food and Drug Administration approved a schizophrenia drug.
More Stories
Oil steadies, but heads for losing week on prospect of increased supply
Oil futures ticked higher Friday, but remained on track for weekly losses on expectations OPEC+ will boost production before year-end...
After U.S. and China ‘panic,’ world market cap set to hit new record, says Bank of America
Global stock-market capitalization is set to surpass its highest level in three years after the Federal Reserve slashed interest rates...
Why Super Micro’s legal woes could be deeper than they appear
Super Micro Computer Inc.’s legal issues may have gotten more complicated, adding another cloud of uncertainty over the once-hot server-maker’s...
Macau Casino owner Las Vegas Sands’ stock extends gains on China stimulus
Las Vegas Sands owns five casinos in Macau, China, which generated $1.75 billion out of a total of $2.76 billion...
U.S. trade deficit in goods shrinks 8.3% in August
Trade gap narrows to $94.3 billion, smallest since March
REA Group makes improved offer to buy U.K.’s Rightmove for $8.3 billion
REA Group’s new offer would give Rightmove’s shareholders a “mix and match” facility, that would let them pick a more...